Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

NCT01755624 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

1-5 Brain Metastases From Non-Small Cell Lung Cancer

Interventions

DEVICE: NovoTTF-100A device
OTHER: Best Standard of Care

Sponsor

NovoCure Ltd.